FMR LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-10 10:47 am Sale | 2024-09-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 1,075,324 2.639% | -1,443,240 (-57.30%) | Filing |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 2,518,564 8.603% | -182,163 (-6.74%) | Filing |
| 2023-10-13 4:01 pm Sale | 2023-10-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 2,700,727 9.227% | -1,502,709 (-35.75%) | Filing |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 4,203,436 14.999% | 6,387 (+0.15%) | Filing |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 4,197,049 14.999% | 1,082,236 (+34.74%) | Filing |
| 2021-07-12 12:07 pm Purchase | 2021-07-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 3,114,813 11.021% | 1,112,825 (+55.59%) | Filing |
| 2021-02-08 10:17 am Purchase | 2021-02-05 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 2,001,988 8.215% | 1,091,399 (+119.86%) | Filing |